Hairy cell leukemia--results with alpha interferon therapy.
No Thumbnail Available
Date
1999-06-22
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Hairy cell leukemia (HCL) is a rare lymphoproliferative disorder. Although now multiple treatment options are being available, the optimal treatment of this disease still remains debatable. Inspite of the advent of newer purine analogues, in India recombinant interferon is the only freely available first line treatment. We report our experience of long term remissions in HCL with interferon alpha 2a. Of a total of 35 cases of HCL we were able to treat 19 cases with interferon. Of 18 evaluable cases an overall response of 88.9% was achieved. With a median follow up of 31 months a disease free survival was 83%. Thus with a dose of 3 million units s.c. daily for 6 months at least, we feel that a reasonably good long term remission can be obtained. The cost of the treatment however, is still a deterrent.
Description
Keywords
Citation
Pai S, Shinde SC, Saikia TK, Gopal R, Nair CN, Advani SH. Hairy cell leukemia--results with alpha interferon therapy. Journal of the Association of Physicians of India. 1999 Jun; 47(6): 605-7